Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Peripheral swelling? 236 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 236 reports of Peripheral swelling have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.6% of all adverse event reports for EMPAGLIFLOZIN.

236
Reports of Peripheral swelling with EMPAGLIFLOZIN
0.6%
of all EMPAGLIFLOZIN reports
11
Deaths
50
Hospitalizations

How Dangerous Is Peripheral swelling From EMPAGLIFLOZIN?

Of the 236 reports, 11 (4.7%) resulted in death, 50 (21.2%) required hospitalization, and 8 (3.4%) were considered life-threatening.

Is Peripheral swelling Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 236 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Peripheral swelling?

ADALIMUMAB (13,837) ETANERCEPT (12,654) METHOTREXATE (10,632) TOCILIZUMAB (8,030) TOFACITINIB (7,830) ABATACEPT (7,561) LEFLUNOMIDE (7,254) LENALIDOMIDE (6,364) HYDROXYCHLOROQUINE (6,128) RITUXIMAB (5,977)

Which EMPAGLIFLOZIN Alternatives Have Lower Peripheral swelling Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Peripheral swelling Reports All Drugs Causing Peripheral swelling EMPAGLIFLOZIN Demographics